Neurofibromatosis News and Research

RSS
Neurofibromatosis is a genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called acoustic neurofibromatosis and NF2.
FDA-approved drug for chemical abortion shows promise for treatment of vestibular schwannoma

FDA-approved drug for chemical abortion shows promise for treatment of vestibular schwannoma

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

Scientists suggest new strategy to inhibit untreatable, deadly nerve sheath tumors

Scientists suggest new strategy to inhibit untreatable, deadly nerve sheath tumors

Exploring the Future of Breast Cancer Risk Assessment

Exploring the Future of Breast Cancer Risk Assessment

UAB study shows missense mutations as key risk factor for severe symptoms of neurofibromatosis type 1

UAB study shows missense mutations as key risk factor for severe symptoms of neurofibromatosis type 1

Research identifies new gene fusions and mutations linked to GIST tumors

Research identifies new gene fusions and mutations linked to GIST tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

TSRI professor receives $2 million grant to study neurofibromatosis type I

TSRI professor receives $2 million grant to study neurofibromatosis type I

Study findings could help identify treatments for balding and hair graying

Study findings could help identify treatments for balding and hair graying

UT Southwestern researchers uncover mechanism linked to balding and hair graying

UT Southwestern researchers uncover mechanism linked to balding and hair graying

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Genetic differences between brain cancer cells and normal tissues could offer clues to tumor behavior

Genetic differences between brain cancer cells and normal tissues could offer clues to tumor behavior

TSRI scientists discover key molecular player in inherited disorder and morphine addiction

TSRI scientists discover key molecular player in inherited disorder and morphine addiction

Neurofibromatosis causes benign tumor formation in normal nervous tissue

Neurofibromatosis causes benign tumor formation in normal nervous tissue

Common pain and anti-inflammation drugs may slow cancer growth

Common pain and anti-inflammation drugs may slow cancer growth

Southern Society bestows 2016 Clinical Science Young Investigator Award to Stansfield

Southern Society bestows 2016 Clinical Science Young Investigator Award to Stansfield

Cancer causing genetic condition risk in children lower than previously thought

Cancer causing genetic condition risk in children lower than previously thought

UAB lab to offer new tests for genetic diseases using next-generation sequencing

UAB lab to offer new tests for genetic diseases using next-generation sequencing

Anticancer drug restores hearing in neurofibromatosis patients

Anticancer drug restores hearing in neurofibromatosis patients

UAB research explores neurofibromatosis type 1

UAB research explores neurofibromatosis type 1